Flanders Vaccine is organising an Elevator Pitch session ‘Connecting the dots’ on Knowledge for Growth (1th June 2023, 2 – 3 PM), the annual business conference of flanders.bio, attracting each year several decision makers, investors, renowned researchers, policymakers and competence providers from all fields of the Life Sciences sector.
O
ne of the main goals of Flanders Vaccine is to bridge the gap between academic research and corporate development by creating awareness about early stage, pre-competitive novel technologies available in the Flanders Vaccine network.
The Flanders Vaccine Elevator Pitch session offers a unique opportunity to connect academic researchers, entrepreneurs, TTO’s, business managers, scientific advisors and investors within the field of Vaccines and Immunotherapy.
Four talented researchers and budding entrepreneurs will present their innovative project to an audience of potential partners and will benefit from the extensive scientific and business experience of the expert panel.
Panel of experts:
Click on their name to see their bio.
Mr Clément Salque
Senior Business Analyst & Immunology Expert, Bioqube Ventures
Mrs Carla Snoeck
Manager New Ventures, VIB Innovation & Business
Mr Tim Van Assche
Director Business Development, eTheRNA
Mrs Najoua Dendouga
Director Business Development, Vaccine R&D, GSK
Mr Stijn Lagaert
European and Belgian Patent Attorney, Gevers
Programme
14:00 Welcome – Prof. Niels Hellings, Prof Immunology UHasselt & Director Biomed
14:05 ImmuneWatch – Implementing AI in the vaccine development process
Tom Bosschaerts, Operations Director ImmuneWatch
14:18 Development of a lipid library development for the optimized delivery of self-amplifying RNA
Magalie Plovyt, Associate Scientist at Ziphius Vaccines
14:31 Putting some jam on the sandwich: addition of cationic peptide encapsulated mRNA turns the layer-by-layer technology
14:31 into a versatile vaccine delivery system – Sabine den Roover, PhD student Vrije Universiteit Brussel
14:44 Paving the way for immunotherapy in pancreatic cancer by a novel combination strategy
Jonas Van Audenaerde, Postdoctoral Researcher Cancer Immunology, University of Antwerp & University Hospital Antwerp
14:57 Closing Word – Prof. Niels Hellings
Interested in pitching?
The call for abstracts is closed.
If you are a young researcher of a university or start-up company with a brilliant idea or innovative technology in the field of vaccine development or immunotherapy with a valuable application to improve human or animal health, don’t miss this opportunity.
What’s in it for you?
- Showcase your innovative project to an audience of potential partners
- Receive constructive feedback and advice from a panel of experts, consisting of investors, innovation managers & business development executives
- Connect with potential partners who could finance and support your project
- A chance to win a financial award from a professional jury.
Practical information
- Thursday June 1th 2023
- Session: 2 – 3 PM
- Flanders Meeting & Convention Center Antwerp, Koningin Astridplein 26, Antwerp, Belgium
More information: Knowledge for Growth 2023
For any further information, please contact:
Flanders Vaccine Project Manager flanders.bio Programme Manager
Fran Van Heuverswyn Katrien Lorré
info@flandersvaccine.be katrien.lorre@flanders.bio
www.flandersvaccine.be www.flanders.bio
Tel.: +32 (0) 11 28 69 04 Tel.: +32 (0) 9 241 80 41